Naive CD4 + T cells are multipotent sentinels of the immune system, poised to respond to instructive signals from antigen-presenting cells by differentiating into distinct effector cell lineages. These include T helper type 1 (T H 1) and T H 2 cells, which are adapted differently for the control of intracellular and extracellular pathogens, respectively, in part through developmentally acquired potential for high expression of distinct cytokine genes 1 . Dysregulated CD4 + T cell development can promote susceptibility to infectious, autoimmune and allergic diseases [2] [3] [4] [5] [6] [7] [8] [9] .
Interleukin 4 (IL-4; A001262), the canonical T H 2 effector cytokine, is also a critical developmental determinant that promotes T H 2 differentiation and inhibits T H 1 differentiation 10 . Recently activated helper T cells make small but functional amounts of IL-4 that induce positive feedback through the IL-4 receptor (A001263) and the transcription factors STAT6 (A002236) and 12) to promote the differentiation of T H 2 cells able to secrete copious amounts of [13] [14] [15] [16] [17] [18] . Thus, regulation of autocrine IL-4 expression by activated helper T cells is a key control point in T helper cell lineage commitment. Nonetheless, the molecular mechanism underlying this regulation is incompletely understood.
T H 2 bias is a complex genetic trait characterized by variation in the propensity of naive helper T cells to differentiate into T H 2 (rather than T H 1) cells. T H 2 bias, measured experimentally as the amount of IL-4 produced by effector CD4 + T cells differentiated in vitro from naive helper T cells activated in 'neutral' conditions (that is, activated without the addition of exogenous cytokines, except IL-2, and cultured without cytokine-specific antibodies), varies over 50-fold from the high-producer phenotype of BALB/c mice to the low-producer phenotype of B10.D2 mice and correlates with susceptibility to T H 2-dependent diseases such as bronchial asthma and leishmaniasis [14] [15] [16] [19] [20] [21] [22] . Various cellular mechanisms have been suggested as the basis for T H 2 bias, including variation in the sensitivity to prostaglandin E 2 -dependent inhibition of interferon-g production 23 , the timing of IL-12 receptor-b2 downregulation 24, 25 and the capacity of activated helper T cells to produce autocrine IL-4 (refs. [14] [15] [16] 20) . Genetic approaches to delineate T H 2 bias have yielded many quantitative trait loci spread across mouse chromosomes 5, 12, 14 15, 16, 17, 18 and 19 (refs. 14,26-29) and a single discrete genetic locus on chromosome 11 (refs. 24,25) . Several quantitative trait loci have been confirmed and isolated as discrete genetic loci by interval-specific congenic mapping 14, 26, 28 . However, so far none of the underlying genetic determinants have been identified.
Here we combine classical genetic and transcriptional profiling analyses to identify Mina, a member of the jumonji C (JmjC) protein family, as a determinant of the T H 2 bias-regulatory locus Dice1b (called 'Dice1.2' here), which was identified by its activity in the autocrine IL-4 pathway of activated helper T cells 28 . We found that T H 2 bias and autocrine Il4 expression correlated inversely with the Mina transcriptional rate, which in turn correlated with a Mina locus haplotype. Consistent with those findings, Mina bound to the Il4 promoter, where it repressed Il4 expression. We propose that a regulatory polymorphism that controls Mina expression in activated helper T cells determines the strength of Mina-dependent Il4 repression and hence the degree of autocrine IL-4 production and, ultimately, the extent of T H 2 differentiation, thereby accounting at least in part for strain-specific differences in T H 2 bias.
RESULTS

Mina is a Dice1.2 candidate gene
Through the use of quantitative trait loci and interval-specific congenic mapping, an Il4-regulatory locus controlling T H 2 bias, Dice1.2, has been mapped to a 26.8-megabase (Mb) genomic interval in chromosome 16 (refs. 14,28 ; Fig. 1a ). To resolve that interval further, we generated the subcongenic strain C16D2/8D, in which the Dice1.2-spanning genomic segment derived from B10.D2 mice (low T H 2 bias) that is present in the congenic strain C16D2/8 on the BALB/c background (high T H 2 bias) 28 is bisected to 14.1 Mb (D16MIT138-MB04; Fig. 1a ). We primed splenic CD4 + T cells from BALB/c, B10.D2 and C16D2/8D mice for 16 h before analyzing Il4 expression by quantitative RT-PCR. As expected, control BALB/c and B10.D2 cells showed phenotypes of high and low T H 2 bias, respectively (Fig. 1b) . The production of Il4 transcripts by C16D2/8D cells was similar to that of B10.D2 cells and was significantly less than that of BALB/c cells (P ¼ 0.0317). This result indicates that Dice1.2 is in the 14.1-Mb C16D2/8D congenic interval that spans from D16MIT138 to MB04 and contains 121 predicted or known genes 30 . As 29 of these encode olfactory receptors, 92 remained as Dice1.2 candidates.
The polymorphisms in Dice1.2 that underlie the genetic variability in T H 2 bias may reside in coding or regulatory sequence. To test for the latter possibility, we investigated genes in the Dice1.2 interval by transcriptional profiling with mRNA isolated from BALB/c and C16D2/8D CD4 + T cells stimulated by T cell antigen receptor (TCR) crosslinking for 16 h, a time at which differences in Il4 expression were nearly maximal. The Affymetrix gene chip we used for initial screening contained 30 Dice1.2 candidate genes. Of these, half were undetectable, and of the remainder, all but one had similar expression in BALB/c and C16D2/8D cells. The one exception was Mina, whose expression was two-to threefold higher in C16D2/8D cells than in BALB/c cells ( Supplementary Fig. 1 ). Although expression profile analysis of the remaining genes in the Dice1.2 interval might identify additional Dice1.2 candidates, we explored here the possibility that Mina acts as a negative regulator of Il4 expression and T H 2 bias.
Inverse correlation of IL-4 and Mina
First, to investigate whether the inverse correlation in the expression of Mina and Il4 in BALB/c and B10.D2 cells could be generalized, we used quantitative RT-PCR to explore their expression in recently activated CD4 + T cells isolated from a panel of independent inbred mouse strains representing phenotypes of high and low T H 2 bias.
Whereas the kinetics of the transcriptional induction of Mina and Il4 was similar across the strains tested, peak magnitudes were very dissimilar and segregated the strains into two discrete groups (Fig. 2a) . In the C57BL/6, B10.D2 and C3H/HeN strains, which have low T H 2 bias, high Mina expression correlated with low Il4 expression, whereas in the BALB/c, DBA/1J, DBA/2J and DBA/2N strains, which have high T H 2 bias, the converse was true (Fig. 2a) . Thus, the inverse correlation in Il4 and Mina expression could be generalized across strains with varying phenotypes of T H 2 bias.
From the analysis reported above of splenic T cell samples enriched for CD4 + cells, it was not clear whether the inverse correlation in the expression of Il4 and Mina occurred in naive progenitor helper T cells or effector helper T cells. To investigate this question, we compared the expression of genes encoding cytokines in highly purified naive helper T cells from BALB/c and C57BL/6 mice. Quantitative RT-PCR analysis of naive helper T cells (99% CD4 + CD62L hi CD44 lo ; less than 0.2% contamination by natural killer T cells) stimulated for 24 h with platebound antibody to TCR (anti-TCR) and anti-CD28 demonstrated an inverse correlation in the expression of Mina and Il4, similar to that in the cell samples enriched for CD4 + cells (Fig. 2b, top) . Next we compared restimulated memory effector cells generated from C57BL/6 helper T cells primed in T H 1 and T H 2 conditions. As expected, Il4 expression was low and high in T H 1-and T H 2-primed cells, respectively (Fig. 2b, bottom) . However, in contrast to naive helper T cells from C57BL/6 and BALB/c mice, T H 1 and T H 2 cells had similar kinetics and magnitude of Mina expression. Thus, the disparate Il4 expression potential of T H 1 and T H 2 cells is not inversely correlated with Mina expression. In contrast, natural variation in the capacity of naive helper T cells to express Il4 is inversely correlated with Mina expression.
Mina acts 'upstream' of IL-4 and IL-12 Two possibilities could account for the inverse correlation in the expression of Il4 and Mina: negative regulation of Il4 by Mina, or negative regulation of Mina by IL-4 signaling. To distinguish between these possibilities, we assessed the abundance of Mina mRNA in activated B10.D2 CD4 + T cells in the presence and absence of exogenously added IL-4. The addition of IL-4 to B10.D2 CD4 + T cells did not diminish its 'high-Mina' phenotype. Conversely, IL-4 neutralization with an IL-4-specific antibody did not enhance the 'low-Mina' phenotype of BALB/c CD4 + T cells (Fig. 2c) . We obtained similar results with highly purified naive helper T cells ( Supplementary Fig. 2a) . Given the ability of IL-12 to promote and inhibit T H 1 development and T H 2 development, respectively, it was also possible that Mina expression was regulated by IL-12. However, neutralization of IL-12 with an IL-12-specific antibody did not diminish the high Mina expression of B10.D2 cells (Fig. 2d) . Furthermore, the addition of IL-12 did not enhance the low Mina expression of BALB/c naive helper T cells ( Supplementary Fig. 2b ). Together these results indicate that neither the IL-4 signaling pathway nor the IL-12 signaling pathway regulates Mina expression, which provides support for the idea that Mina acts as a negative regulator of Il4 expression in naive helper T cells.
Mina is transcriptionally regulated
We next sought to determine whether differences in Mina transcript abundance led to differences in Mina protein abundance. We activated purified BALB/c and C57BL/6 naive helper T cells over a 72-hour time course with plate-bound anti-TCR and anti-CD28 and analyzed the resulting nuclear and cytoplasmic extracts by immunoblot with a Mina-specific antibody (Fig. 3a) . Whereas cytosolic Mina increased with time, nuclear Mina appeared transiently, peaking around 24 h in both BALB/c cells and C57BL/6 cells. In both subcellular compartments, Mina protein amounts were consistently higher (about two-to fivefold) in C57BL/6 cells than in BALB/c cells, which demonstrated tight linkage between the abundance of Mina protein and that of Mina mRNA. To determine whether Mina was regulated transcriptionally, we exploited the fact that the abundance of pre-mRNA correlates with transcriptional rate 31 . Measurement of Mina pre-mRNA abundance showed higher expression in newly activated C57BL/6 helper T cells than in newly activated BALB/c helper T cells, which correlated with the differences in Mina mRNA abundance (Fig. 3b) . These results collectively indicate that Mina protein abundance is transcriptionally regulated.
To explore whether regulatory polymorphisms could account for the differences in Mina transcription in strains with high and low T H 2 bias, we sequenced the 5¢ end of the Mina genomic locus (including intron 1 and 1,304 base pairs (bp) of the promoter) from strains with high T H 2 bias (BALB/c and DBA/2J) and those with low T H 2 bias (C57BL/6, B10.D2/OsnJ and C3H/HeN). We identified 21 singlenucleotide polymorphisms (SNPs) that precisely defined two haplotypes (Fig. 4) that correlated with the phenotypes of T H 2 bias and Mina expression (Fig. 2) . Thus, Mina haplotypes are a useful genetic Mina  SNP17  SNP16  CNS5   SNP15   SNP13  SNP10   SNP1  SNP5  SNP2  SNP3  SNP4  SNP9  SNP8  SNP7  SNP6  CNS4 CNS3 CNS2 CNS1 CDS SNP11 SNP12 SNP14 CNS6 Figure 4 Mina haplotype can be used to predict T H 2-bias phenotype. (a) Promoter-proximal end of the Mina genomic locus, showing the 21 SNPs identified across this interval, along with exons (red), the coding region (yellow) and conserved noncoding sequences (CNS1-CNS6; cyan). (b) Position (relative to the translational start site in exon 2) and allelic identity of each SNP for three strains with low T H 2 bias (red) and two strains with high T H 2 bias (green; -indicates a gap in the sequence). marker for T H 2 bias and may contain regulatory polymorphisms responsible for differences in Mina expression across strains with distinct phenotypes of T H 2 bias.
Mina specifically binds and represses the Il4 promoter
To investigate whether Mina can repress transcription from the Il4 promoter, we did transient reporter assays, cotransfecting 68-41 mouse T cell hybridoma cells with a Mina or empty expression vector and a luciferase reporter driven by either an Il4 promoter or an Il2 promoter 32 . Mina inhibited luciferase activity driven by the Il4 promoter but not activity driven by the Il2 promoter (Fig. 5a) . To define the Mina-responsive region in the 766-bp Il4 promoter, we used the transient reporter assay to study a series of Il4 promoter deletion mutants. Neither truncation of the Il4 promoter to 300 bp nor truncation to 140 bp was sufficient to eliminate sensitivity to Minadependent repression (Fig. 5a) . Thus, a target site for the repressive activity of Mina is in the first 140 bp of the Il4 promoter.
To further refine the Mina responsive region, we used electrophoretic mobility-shift assay (EMSA). We tested nuclear extracts isolated from TCR-stimulated B10.D2 CD4 + T cells against a series of end-labeled DNA probes spanning the first 140 bp of the Il4 promoter (Fig. 5b) . Nucleoprotein complexes were formed with probe A (positions -188 to -158) and probe B (positions -157 to -128) but not probe C (positions -127 to -98) or probe D (positions -97 to -69; Fig. 5c) ; however, only the probe B complex was sensitive to disruption by a Mina-specific antibody. Thus, Mina can associate with the Il4 promoter over the 30-bp region of probe B that extends from position -157 to position -128.
To determine whether Mina binds to the Il4 promoter in vivo, we used anti-Mina for chromatin immunoprecipitation (ChIP) analysis of BALB/c and B10.D2 CD4 + T cells that had been activated for 24 h. Consistent with the binding activity detected by EMSA in the region from position -157 to position -128, we found Mina enrichment in the Il4 promoter but not in the promoter of the gene encoding CD3e (Fig. 5d) . Furthermore, the magnitude of binding activity at the Il4 promoter was consistently higher in B10.D2 cells than in BALB/c cells, which correlated with the relative expression of Mina in these two strains (Fig. 2e) . A broad ChIP survey of the entire T H 2 locus in B10.D2 CD4 + T cells activated for 24 h also detected a strong peak of Mina binding at the Il4 promoter ( Supplementary Fig. 3 ). These data collectively support a model in which Mina is recruited to the proximal Il4 promoter, where it exerts a concentration-dependent transcription-repressive effect.
Recruitment of Mina to the Il4 promoter requires NFAT As Mina lacks a predicted DNA-binding domain, it is likely that its recruitment to the Il4 promoter is indirect. Probe B contains published binding sites for the transcription factors NFAT (NFATc1 (A001640) and NFATc2 (A000024)) and Oct 33, 34 , which raises the possibility of their involvement in recruiting Mina to the Il4 promoter (Fig. 6a) . To test this possibility, we used wild-type probe B and a mutant probe B (B NM ) unable to bind NFAT 34 for EMSA with nuclear extracts from the T cell thymoma line EL4, which expresses Mina 35 . Nuclear extracts from activated but not resting EL4 cells (and C57BL/6 CD4 + T cells) formed a nucleoprotein complex with wild-type probe B ( Supplementary Fig. 4 ). This complex was sensitive to disruption by a Mina-specific antibody (Fig. 6b) , which indicated that the probe B complex formed with EL4 extracts, like that formed with B10.D2 CD4 + T cell extracts, contained Mina. Although a wild-type NFAT consensus sequence was able to compete with probe B for complex formation, a wild-type Oct consensus sequence did not (data not shown), which suggests that the Mina complex contains NFAT but not Oct. Furthermore, a probe B mutant unable to bind Oct was still able to form the Mina complex (data not shown). Thus, Oct is neither a constituent of the Mina-probe B complex nor required for recruitment of Mina to the Il4 promoter.
The formation of higher-order complexes with anti-NFATc1 and anti-NFATc2 confirmed the presence of both NFAT proteins in the probe B-Mina complex (Fig. 6b and data not shown) . The mutant probe B NM that is unable to bind NFAT 34 did not form the Mina complex and failed to compete with probe B for complex formation ( Fig. 6b) , which suggests a requirement for NFAT in Mina recruitment. To confirm that idea, we did DNA precipitation assays with biotinylated probes B and B NM . Whereas both Mina and NFAT (NFATc1 and NFATc2) could be precipitated together with the biotinylated wild-type probe B, probe B NM failed to precipitate together with either NFAT protein or Mina (Fig. 6c and data not  shown) . Notably, a biotinylated NFAT-binding sequence from the Il2 promoter failed to precipitate Mina despite binding both NFATc1 and NFATc2 (Fig. 6c and data not shown) , which indicated that NFATc1 and NFATc2 were insufficient for Mina recruitment. Finally, nuclear extracts of cells treated with the calcineurin inhibitor cyclosporin A, to prevent NFAT dephosphorylation and nuclear translocation, failed to form the Mina nucleoprotein complex ( Supplementary Fig. 4 ). These data collectively suggest that NFAT is necessary but not sufficient for recruitment of Mina to the Il4 promoter-specific nucleoprotein complex.
Mina is necessary and sufficient to constrain IL-4 expression
To directly test whether Mina can repress Il4 transcription in CD4 + T cells, we generated three independent BDF1 Â C57BL/6 mouse lines expressing a Mina transgene driven by a lymphocyte-specific proximal promoter-E m enhancer of the gene encoding the kinase Lck 36 . We analyzed mice after three backcrosses to BALB/c mice, at which point they showed normal T cell development and expression of activation markers (data not shown). Using quantitative RT-PCR to compare Mina expression in CD4 + T cells, we found that all three transgenic lines had high basal Mina expression that diminished over a 48-h activation time course to lower expression similar to or higher than the peak of expression by their respective wild-type littermate controls (Fig. 7) . To determine the effect of a transient enforced increase in Mina abundance on cytokine gene expression, we examined the transcriptional induction of Il2 and Il4 and of the gene encoding interferon-g (Ifng). Expression of Il4 was considerably impaired in all three Mina-transgenic lines relative to its expression in wild-type littermate controls, but expression of Il2 and Ifng was not (Fig. 7) . Thus, a transient enforced increase in Mina in CD4 + T cells specifically impairs expression of Il4 but not of Il2 or Ifng.
To test whether Mina-dependent repression is required to maintain normal expression of Il4, we used antisense morpholino technology to 'knock down' Mina protein in primary CD4 + T cells. At 24 h after activation, C57BL/6 CD4 + T cells pretreated for 16 h with Minamorpholino expressed half the amount of Mina protein expressed by cells given mock pretreatment or pretreatment with controlmorpholino (Fig. 8) . In contrast, cells pretreated with Minamorpholino expressed about twofold more Il4 mRNA (but not more Ifng mRNA) than did cells given mock pretreatment or pretreatment with control-morpholino (Fig. 8) . Thus, the quantitative potential of CD4 + T cells to express Il4 is normally constrained by tight Mina-dependent negative regulation.
DISCUSSION
We have identified Mina as a genetic determinant of the Il4-and T H 2 bias-regulatory locus Dice1.2. Our data suggest that Mina is a necessary and sufficient dose-dependent Il4-specific repressor in naive helper T cells that affects the magnitude of the early autocrine IL-4 burst required for the 'programming' of T H 2 development. Furthermore, our results have shown how natural variation in Mina transcription (probably due to regulatory SNPs at the Mina locus) contributes to natural variation in T H 2 bias.
Mina belongs to the Jmj protein family whose hallmark JmjC domain is homologous to the family of Fe(II)-and 2-oxoglutaratedependent dioxygenase enzymes. The catalytic dioxgyenase core comprises three iron-binding residues and two 2-oxoglutaratebinding residues, of which four are conserved in Mina 37 . Dioxygenases can catalyze a variety of post-translational modifications on substrate proteins, including demethylation and hydroxylation. For example, JMJD6, a member of the JmjC-only subfamily (to which Mina belongs), has been shown to have histone arginine-demethylase activity 38 , and FIH (also a member of the JmjC-only subfamily) is an asparagine hydroxylase, responsible for inactivating the transcriptional activation domain of hypoxia-inducing factor 39, 40 . Despite imperfect conservation of its core catalytic residues, Mina is a 44 . Finally, it is possible that the Il4-repressive effect of Mina may be mediated by a mechanism independent of its dioxygenase activity. Mina, which lacks an obvious DNA-binding domain, associates with a region of the Il4 promoter that contains binding sites for NFAT and Oct. Our results have indicated that whereas Oct is excluded from the Mina complex, an NFAT-dependent interaction is required for recruitment of Mina to the Il4 promoter. However, although it is necessary, NFAT is not sufficient for recruitment of Mina to the Il4 complex, as it did not associate with an Il2 promoter fragment able to recruit both NFATc1 and NFATc2. This result indicates the existence of specificity-determining sequence elements in addition to those required for NFAT recruitment. Identification of these elements may assist in the identification of factors required along with NFAT to recruit Mina to the Il4 promoter.
Mina was first identified as a nuclear antigen of 53 kilodaltons induced by the myelocytomatosis oncogene product Myc and was found to be overexpressed and associated with poor prognosis in a variety of human cancer cells [45] [46] [47] [48] . Studies using ChIP and tamoxifeninducible fusion protein Myc-ERTam have shown that Mina is a direct target of Myc in human promyelocytic leukemia and human glioblastoma cells 48 . Comparison of the Mina promoter sequence in strains with high or low T H 2 bias failed to demonstrate polymorphism in a presumptive Myc-binding site (data not shown), which suggests that differences in Myc activity may not be responsible for the differences in Mina expression in strains with high or low T H 2 bias. Furthermore, Myc expression in activated naive helper T cells is similar in strains with high or low T H 2 bias, and its acute deletion does not impair Mina expression in naive helper T cells (M. Koyanagi, unpublished data). Thus, in naive helper T cells, Mina may not be a true Myc target.
There are 21 SNPs of the Mina promoter and intron 1 that define two distinct haplotypes that correlate with Mina expression phenotype. The polymorphisms that underlie the differences in Mina expression probably reside in a key regulatory element whose function is modulated by one or several of the 21 (or perhaps additional) haplotype-defining SNPs. Phylogenetic sequence conservation has been used to identify gene-regulatory elements as regions of 'conserved noncoding sequence' 49 . We have identified six conserved noncoding sequences in the 5-kilobase region of the Mina locus containing the 21 SNPs. Four of the twenty-one haplotype-defining SNPs (1, 2, 5 and 10) are in three conserved noncoding sequences (4, 2 and 1) and are thus candidates for the functional regulatory polymorphisms that underlie the differences in Mina expression that distinguish strains with high or low T H 2 bias. The identification of Mina-regulatory polymorphisms will provide candidates for the causative Dice1.2 genetic lesion and a foothold for delineation of the critical 'upstream' pathways.
Although differences in Mina expression can explain the Il4-and T H 2 bias-regulatory activity of Dice1.2, it remains possible that other genes in the minimal Dice1.2 interval contribute to the T H 2 biasregulatory activity of Dice-1.2. Furthermore, Dice1.2 is one of two Il4-and T H 2 bias-regulatory loci originally identified on chromosome 16 (the other being Dice1a, called 'Dice1.1' here) 28 . Thus, identification of the molecular basis of the action of Dice1.1 will probably add further mechanistic insight into the complex regulation of Il4 and T H 2 bias. Notably, Dice1.2 (but not Dice1.1) is tightly linked genetically to a host response-modifying locus (LmrA) for the protozoan parasite Leishmania major that is responsible for leishmaniasis 28 . As T H 2 bias is critical in determining susceptibility to leishmaniasis, it is possible that Mina is LmrA. In this context, it is perhaps relevant that among hematopoietic cell types, Mina is expressed in CD4 + T cells and dendritic cells; the latter cell type has also been suggested to contribute to the different T H 2-bias phenotypes of BALB/c and B10.D2 mice. A dual T H 2 bias-regulatory function for Mina (with separate activities in naive helper T cells and dendritic cells) could explain the linkage of Dice1.2 but not Dice1.1 to LmrA. Investigation of the function of Mina in dendritic cells may thus provide further insight into the mechanism of T H 2 bias.
Our data have identified a previously unknown IL-4-repressive pathway in which Mina serves a key function in regulating the amount of IL-4 produced by naive helper T cells, thereby controlling the extent of T H 2 differentiation and T H 2 bias. Natural genetic variation in this pathway contributes to the variation in T H 2 bias characteristic of distinct inbred mouse strains. It will be important to determine the 'upstream' regulators, 'downstream' targets and repressive mechanism of Mina and the extent to which the Mina pathway may be conserved and manipulated in humans.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
Accession codes. UCSD-Nature Signaling Gateway (http://www. signaling-gateway.org): A001262, A001263, A002236, A001640 and A000024; Reference Database of Immune Cells of the Research Center for Allergy and Immunology 50 : microarray data, RMSPTB007001 and RMSPTB008001.
Note: Supplementary information is available on the Nature Immunology website.
